Raymond James Financial’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$99.5M	Sell	791,526 -956	-0.1%	-$120K	0.03%	481
2025 Q1	$87.6M	Sell	792,482 -51,420	-6%	-$5.69M	0.03%	476
2024 Q4	$115M	Buy	+843,902	New	+$115M	0.04%	387